Literature DB >> 7092351

Effect of methionine-enkephalin and naloxone on bombesin-stimulated gastric acid secretion, gastrin, and pancreatic polypeptide release in the dog.

A Materia, B M Jaffe, I M Modlin, A Sank, D Albert.   

Abstract

In four dogs with chronic gastric fistulae, bombesin infusion was used to stimulate the release of gastrin and pancreatic polypeptide (PP) as well as rates of gastric acid secretion. Neither methionine-enkephalin (met-enkephalin) nor naloxone alone or the combination of these agents altered bombesin-stimulated gastrin release. met-enkephalin alone (but not naloxone) significantly inhibited the gastric secretory response to bombesin, but this inhibitory effect was not influenced by the simultaneous infusion of naloxone; the data suggested that the effect of met-enkephalin was indirect, and perhaps modulated by another inhibitory mechanism. Whereas PP release induced by bombesin was not affected by naloxone, it was significantly suppressed by met-enkaphalin; since this inhibition was virtually totally reversed by naloxone, the data suggested that the effect of opiate peptides on the release of pancreatic polypeptide was direct and mediated by a specific opiate receptor.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7092351      PMCID: PMC1352496          DOI: 10.1097/00000658-198207000-00011

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  18 in total

1.  Effects of bombesin and bombesin-like peptides on gastrointestinal myoelectric activity.

Authors:  R Caprilli; P Melchiorri; G Improta; P Vernia; G Frieri
Journal:  Gastroenterology       Date:  1975-05       Impact factor: 22.682

2.  Met-enkephalin-immunoreactive and gastrin-immunoreactive cells in the human and canine pyloric antrum.

Authors:  S Ito; K Takai; A Shibata; Y Matsubara; N Yanaihara
Journal:  Gen Comp Endocrinol       Date:  1979-06       Impact factor: 2.822

3.  Mediation by 5-hydroxytryptamine of morphine stimulant actions in dog intestine.

Authors:  T F Burks
Journal:  J Pharmacol Exp Ther       Date:  1973-06       Impact factor: 4.030

4.  Endogenous opiates and gastric acid secretion.

Authors:  T E Solomon
Journal:  Gastroenterology       Date:  1980-02       Impact factor: 22.682

5.  Release of intestinal 5-hydroxytryptamine by morphine and related agents.

Authors:  T F Burks; J P Long
Journal:  J Pharmacol Exp Ther       Date:  1967-05       Impact factor: 4.030

6.  Leu-enkephalin-like material in nerves and enterochromaffin cells in the gut. An immunohistochemical study.

Authors:  J Alumets; R Håkanson; F Sundler; K J Chang
Journal:  Histochemistry       Date:  1978-07-12

7.  Inhibitory effect of enkephalins on contractions of the guinea-pig ileum elicited by PGE1.

Authors:  R Jaques
Journal:  Agents Actions       Date:  1977-09

8.  Effect of bombesin infused intrapancreatically on glucagon and insulin secretion.

Authors:  A Kaneto; T Kaneko; S Nakaya; H Kajinuma; K Kosaka
Journal:  Metabolism       Date:  1978-05       Impact factor: 8.694

9.  Comparison of methionine-enkephalin and morphine in the stimulation of gastric acid secretion in the dog.

Authors:  S J Konturek; J Tasler; M Cieszkowski; E Mikoś; D H Coy; A V Schally
Journal:  Gastroenterology       Date:  1980-02       Impact factor: 22.682

10.  Enkephalin-like immunoreactivity in the human gastrointestinal tract.

Authors:  J M Polak; S R Bloom; S N Sullivan; P Facer; A G Pearse
Journal:  Lancet       Date:  1977-05-07       Impact factor: 79.321

View more
  2 in total

1.  Influence of methionine-enkephalin analogue (FK-33-824) on the secretion of pancreatic hormones.

Authors:  K Sekiya; A Funakoshi; H Shinozaki; H Nawata; K Kato; H Ibayashi
Journal:  Gastroenterol Jpn       Date:  1985-06

2.  Influence of acute exposure to high altitude on basal and postprandial plasma levels of gastroenteropancreatic peptides.

Authors:  Rudolf L Riepl; Rainald Fischer; Hubert Hautmann; Gunther Hartmann; Timo D Müller; Matthias Tschöp; Marcell Toepfer; Bärbel Otto
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.